IP Library Granted Patent US 10,420,744
Granted Patent B2
US 10,420,744 · App. 15/936,376 · Granted Sep 24, 2019

Composition of chlorogenic acid and methods of making and using the same in treating serum lipid levels

Inventors: Kodimule Shyam Prasad (Bangalore, IN); Harakanahalli Lingaraju Basavegowda (Bangalore, IN)
Assignee: Vidya Herbs, Inc.
A61K31/216A61K36/74A61K2236/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,420,744
App. No.
15/936,376
Filed
Mar 26, 2018
Granted
Sep 24, 2019
Kind
B2
Art Unit
1625
USPC
514/533
Abstract

The present invention is directed compositions derived from green coffee bean extract and methods for the use and manufacture of such compositions. The compositions of the invention have unique ratios of chlorogenic acids which offer a therapeutic effect in the treatment of a variety of conditions and disorders. Methods for using the compositions of the invention include, but are not limited to, methods for treating obesity and methods for regulating serum lipids.

Claims (21)

1. A method of treating serum lipid levels, said method comprising:

administering to a subject in need thereof a composition comprising a mixture of chlorogenic acids, said mixture comprising 12.5% 3-caffeoylquinic acid (3-CQA), 46.9% 5-caffeoylquinic acid (5-CQA), 17.2% 4-caffeoylquinic acid (4-CQA), 4.6% 5-feruloylquinic acid (5-FQA), 6.2% 3,4 dicaffeoylquinic acid (3,4 di CQA), 4.6% 3,5 dicaffeoylquinic acid (3,5 di CQA), and 8.0% 4,5 dicaffeoylquinic acid (4,5 di CQA);

wherein administering said composition modulates the level of at least one lipid in the serum of said subject.

2. The method of claim 1 , wherein administering said composition reduces triglycerides in the serum of said subject.

3. The method of claim 1 , wherein administering said composition reduces cholesterol in the serum of said subject.

4. The method of claim 1 , wherein administering said composition increases high density lipids in the serum of said subject.

5. The method of claim 1 , wherein administering said composition decreases low density lipids in the serum of said subject.

6. The method of claim 1 , wherein administering said composition reduces very low density lipids in the serum of said subject.

7. The method of claim 1 , wherein administering said composition improves the lipid profile of said subject.

8. The method of claim 1 , wherein said subject has hyperlipidemia.

9. The method of claim 1 , wherein said subject is overweight.

10. The method of claim 1 , wherein said mixture of chlorogenic acids is made from coffee beans.

11. The method of claim 10 , wherein said coffee beans are green coffee beans dried coffee beans, or a combination thereof.

12. The method of claim 10 , wherein said coffee beans are Coffea arabica coffee beans.

13. The method of claim 1 , wherein said mixture of chlorogenic acids is made from coffee bean pulp.

14. The method of claim 1 , wherein said composition is administered orally to said subject.

15. The method of claim 1 , wherein said composition further comprises a pharmaceutically acceptable excipient.

16. The method of claim 1 , wherein said composition comprises about 20% w/w to about 60% w/w chlorogenic acid.

17. The method of claim 1 , wherein the form of said composition is selected from the group consisting of a powder, pill, tablet, pellet, granule, capsule, film, solution, spray, syrup, linctus, lozenge, pastille, chewing gum, paste, vapor, suspension, emulsion, ointment, cream, lotion, liniment, gel, drop, topical patch, buccal patch and injection.

18. The method of claim 1 , wherein said composition is a liposomal formulation.

19. The method of claim 1 , wherein said is human.

Continuity (4)
Continuation 15626125 · Jun 18, 2017
Continuation 14814494 · Jul 30, 2015
Provisional Application 62031135 · Jul 30, 2014
Related Publication 20180311198A1 · Nov 1, 2018
Cited By (6)
US 12,280,030 US 12,349,710 US 12,419,335 US 12,458,049 US 12,569,528 US 12,662,505